{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-067858","form_type":"8-K","ticker":"LFST","cik":"0001845257","company_name":"LifeStance Health Group, Inc.","filed_at":"2026-02-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.512686+00:00","generated_at":"2026-05-16T00:27:48.182579+00:00","sec_items":["2.02","5.02","7.01","8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"LifeStance Q4 revenue $382M (+17% YoY); net income $11.7M; $100M buyback; Chairman transition","bullets":["Q4 revenue $382.2M (+17% YoY); full-year revenue $1.42B (+14% YoY).","Q4 net income $11.7M vs loss $7.1M; full-year net income $9.7M vs loss $57.4M.","Adjusted EBITDA Q4 $48.8M (+49% YoY); full-year $157.7M (+32% YoY).","2026 guidance: revenue $1.615B-$1.655B; Adjusted EBITDA $185M-$205M.","Board approved $100M share repurchase; Kenneth Burdick transitions to non-executive Chairman effective Mar 16, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-067858","json":"https://secwatch.observer/filing/0001193125-26-067858.json","markdown":"https://secwatch.observer/filing/0001193125-26-067858.md","text":"https://secwatch.observer/filing/0001193125-26-067858.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1845257/000119312526067858/0001193125-26-067858-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1845257/000119312526067858/lfst-20260225.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T00:27:48.182579+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}